N-SAS BC06: A phase III study of adjuvant endocrine therapy with or without chemotherapy for postmenopausal breast cancer patients who responded to neoadjuvant letrozole (LET): The New Primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results